Twist Bioscience Corporation
TWSTTwist Bioscience is a life sciences company that has developed a proprietary silicon-based DNA synthesis platform to industrialize the engineering of biology.
Earnings
Next report
Aug 3, 2026 (In 5 days)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Twist Bioscience is a life sciences company that has developed a proprietary silicon-based DNA synthesis platform to industrialize the engineering of biology. By miniaturizing chemical reactions on a silicon chip, the company manufactures high-quality synthetic DNA, RNA, and proteins at a significantly higher throughput and lower cost than traditional methods. Their technology serves as a foundational tool for innovation in healthcare, agriculture, industrial chemicals, and academic research.
Twist is a leading disruptor in DNA synthesis, utilizing a proprietary silicon-based 'writing' technology that offers superior scale and cost-efficiency compared to legacy plate-based manufacturers.
Questions, answered.
- What is Twist Bioscience Corporation's market cap?
- Twist Bioscience Corporation (TWST) has a market capitalization of $5.4B and trades on NASDAQ.
- What is Twist Bioscience Corporation's revenue and profitability?
- Twist Bioscience Corporation generated $409.5M in trailing twelve-month revenue with a net loss of $81.3M, representing a net margin of -19.8%. Gross margin stands at 52.1%, with free cash flow of -$95.0M. These figures are based on the Q1 2026 filing.
- Who are Twist Bioscience Corporation's competitors?
- Twist Bioscience Corporation's key competitors include Illumina, Inc., Integrated DNA Technologies, Inc., Agilent Technologies, Inc., and others. These companies compete in similar markets and product categories.
- Who does Twist Bioscience Corporation partner with?
- Twist Bioscience Corporation's notable partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited, and others.
- Where is Twist Bioscience Corporation headquartered?
- Twist Bioscience Corporation is headquartered in United States of America and employs approximately 919 people. It has been publicly traded since 2018.
